MetLife Inc's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 22 out of 115 in the Insurance industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 93.21.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of MetLife Inc is 7.28, ranking 44 out of 115 in the Insurance industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 17.38B, representing a year-over-year decrease of 6.08%, while its net profit experienced a year-over-year decrease of 35.84%.
Key Metrics
The current valuation score of MetLife Inc is 7.40, ranking 54 out of 115 in the Insurance industry. Its current P/E ratio is 14.77, which is 175.57% below the recent high of 40.69 and 42.07% above the recent low of 8.55.
The current earnings forecast score of MetLife Inc is 7.88, ranking 24 out of 115 in the Insurance industry. The average price target is 92.50, with a high of 108.00 and a low of 81.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of MetLife Inc is 7.31, ranking 48 out of 115 in the Insurance industry. Currently, the stock price is trading between the resistance level at 82.96 and the support level at 74.84, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of MetLife Inc is 7.00, ranking 40 out of 115 in the Insurance industry. The latest institutional shareholding proportion is 77.75%, representing a quarter-over-quarter decrease of 15.41%. The largest institutional shareholder is The Vanguard, holding a total of 72.26M shares, representing 10.97% of shares outstanding, with 28.79% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Insurance domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of MetLife Inc is 9.10, ranking 28 out of 115 in the Insurance industry. The company's beta value is 0.76. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. MetLife Inc’s latest ESG disclosure is at an average level in the Insurance industry, showing no material impact on overall risk.
